PLYMOUTH MEETING, Pa. – October 26, 2015 – Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that the Company will host its third quarter 2015 financial results conference call and live webcast on Monday, November 9 at 8:30 AM ET.
A live and archived version of the webcast presentation will be available online at http://www.investorcalendar.com/IC/CEPage.asp?ID=174407 as well as through the “Webcast” tab on Inovio’s home page at www.inovio.com. This will be a listen-only event but will include a live Q&A with analysts following the corporate update.
A replay of the conference call will be accessible two hours after the call at 877-660-6853 (domestic) or 201-612-7415 (international) using passcode 13622033.
About Inovio Pharmaceuticals, Inc.
Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that is generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, Roche, University of Pennsylvania, DARPA, GeneOne Life Science, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and University of Manitoba. For more information, visit www.inovio.com. CONTACTS: Investors: Bernie Hertel, Inovio Pharmaceuticals, 858-410-3101, bhertel@inovio.com Media: Jeff Richardson, Inovio Pharmaceuticals, 267-440-4211, jrichardson@inovio.com
Help employers find you! Check out all the jobs and post your resume.
